| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9974567 | The Journal of Heart and Lung Transplantation | 2005 | 6 Pages |
Abstract
Tacrolimus-based immunosuppression yields promising long-term results in HKTx and HTx. The incidence of transplant vasculopathy seems to be lower after HKTx than after HTx. If these results are secondary to a protective effect of tacrolimus-induced tolerance or of tolerance-associated co-transplantation they will need to be investigated in prospective multicenter trials.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Jan MD, Ingo MD, Markus MD, Stefan MS, Andre MS, Sabine MD, Helmut MD, Bruno MD, Bruno MD,